Furthermore, in this constant quest for predictive biomarkers, a deeper investigation of the relevance of anti-HSP autoantibodies in RA-ILD may be interesting in order to anticipate and mitigate their pulmonary manifestations (Figure 2, Table 2). The gene discussed is HSP90B2P; the disease is rheumatoid arthritis.